This inventor holds 1 USPTO granted patent. Top assignee: Temasek Life Sciences Laboratory Limited. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Anbu Kumar Karuppannan: Innovator in Antigenic Protein Display
Introduction
Anbu Kumar Karuppannan is a notable inventor based in Singapore, recognized for his contributions to the field of biotechnology. He has developed innovative solutions that enhance the efficiency of antigenic protein display, which is crucial for various applications in medical and research settings.
Latest Patents
Anbu Kumar Karuppannan holds a patent for an "Expression cassette for efficient surface display of antigenic proteins." This expression cassette comprises an ie 1 promoter from the white spot syndrome virus or a variant thereof. It includes a nucleic acid sequence encoding an N-terminal gp64 signal peptide or a variant thereof, a nucleic acid sequence encoding an antigenic peptide, a nucleic acid encoding a transmembrane region, and a nucleic acid encoding a gp64 cytoplasmic region or a variant thereof. The promoter is operably linked to the nucleic acid sequence, showcasing a sophisticated approach to protein expression.
Career Highlights
Anbu Kumar Karuppannan is currently associated with Temasek Life Sciences Laboratory Limited, where he continues to push the boundaries of scientific research. His work focuses on developing innovative methodologies that can significantly impact the field of biotechnology.
Collaborations
Throughout his career, Anbu has collaborated with esteemed colleagues, including Premanand Balraj and Hwei-Sing Jimmy Kwang. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Anbu Kumar Karuppannan is a distinguished inventor whose work in antigenic protein display has the potential to advance biotechnological applications. His contributions reflect a commitment to innovation and excellence in the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile